FRIENDSWOOD, Texas, Oct. 15, 2026 /PRNewswire/ — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the third quarter and nine months ended Sept. 30, 2026,…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
